Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma.

G Peiró, F Ortiz-Martínez, A Gallardo, A Pérez-Balaguer, J Sánchez-Payá, JJ Ponce, A Tibau, L López-Vilaro, D Escuin, E Adrover, A Barnadas, E Lerma

Research output: Contribution to journalArticleResearch

49 Citations (Scopus)
Original languageEnglish
Pages (from-to)689-695
JournalBr J Cancer. PMID: 24937674. Q1 (onc0) IF: 4,817
Volume111
Issue number4
Publication statusPublished - 1 Jan 2014

Cite this

Peiró, G., Ortiz-Martínez, F., Gallardo, A., Pérez-Balaguer, A., Sánchez-Payá, J., Ponce, JJ., Tibau, A., López-Vilaro, L., Escuin, D., Adrover, E., Barnadas, A., & Lerma, E. (2014). Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma. Br J Cancer. PMID: 24937674. Q1 (onc0) IF: 4,817, 111(4), 689-695.